Landi, D., Archer, G., Driscoll, T., Lipp, E., Archambault, B., Thompson, E., … Ashley, D. (2020). CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS. In NEURO-ONCOLOGY (Vol. 22, pp. 306–306).

Landi, Daniel, Gary Archer, Timothy Driscoll, Eric Lipp, Bridget Archambault, Eric Thompson, Charlene Flahiff, et al. “CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS.” In NEURO-ONCOLOGY, 22:306–306, 2020.

Landi D, Archer G, Driscoll T, Lipp E, Archambault B, Thompson E, et al. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS. In: NEURO-ONCOLOGY. 2020. p. 306–306.

Landi, Daniel, et al. “CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS.” NEURO-ONCOLOGY, vol. 22, 2020, pp. 306–306.

Landi D, Archer G, Driscoll T, Lipp E, Archambault B, Thompson E, Flahiff C, Jaggers D, Hahn K, Healy P, Ramirez L, Herndon J, Schroeder K, Sampson J, Ashley D. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS. NEURO-ONCOLOGY. 2020. p. 306–306.